2000
DOI: 10.1007/s004150050562
|View full text |Cite
|
Sign up to set email alerts
|

Quality of life in patients with axonal polyneuropathy

Abstract: "Quality of life" (QOL) measurement reflects the impact of a disease on the daily life of a patient, and this can be used as an outcome measure in clinical trials. QOL measurements are rarely used in patients with neuromuscular disease. The aim of this study was to determine whether QOL is reduced in chronic polyneuropathy, whether there is a relationship between QOL and objective measures of disease severity, and whether measuring QOL is a useful addition to the assessment of severity of polyneuropathy. We me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
18
0

Year Published

2001
2001
2018
2018

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 45 publications
(20 citation statements)
references
References 16 publications
2
18
0
Order By: Relevance
“…The differences in 'social functioning', 'pain', and 'physical functioning' were most marked [16]. The patients and the reference population were not sex-and age-matched.…”
Section: Discussionmentioning
confidence: 96%
See 2 more Smart Citations
“…The differences in 'social functioning', 'pain', and 'physical functioning' were most marked [16]. The patients and the reference population were not sex-and age-matched.…”
Section: Discussionmentioning
confidence: 96%
“…Patients had lower scores than the reference population on seven of eight areas on the scale. The greatest differences were on 'social functioning', 'pain', and 'physical functioning' [16]. Because QOL is not described well in patients with cryptogenic polyneuropathy, it is difficult to provide the patients with accurate information about the possible impact of the disease on daily living.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…These results are consistent with reports of presence of pain in other studies in FSHD and HMSN. [14][15][16] Pain, particularly back pain, is often cited as a problem but has been poorly studied in MD patients. 32 Age and fatigue severity did not seem to be related in any of the groups, as no contribution of these variables was found in the regression analyses.…”
Section: Discussionmentioning
confidence: 99%
“…13 Most psychological studies in neuromuscular disorders, however, have focused mainly on disability or loss of quality of life, and did not address the problem of experienced fatigue among different neuromuscular disorders. [14][15][16] Currently, no cross sectional study has compared the presence and severity of fatigue in various neuromuscular diseases using validated instruments.…”
mentioning
confidence: 99%